129 related articles for article (PubMed ID: 19065903)
1. [Intervening effect of naoxintong on anti-platelet treatment with aspirin].
Chen DK; Zhang HQ; Zhang JH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Sep; 28(9):843-6. PubMed ID: 19065903
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation through the efficacy of aspirin in congenital heart disease patients undergoing transcatheter closure of atrial septal defects or ventricular septal defects.
Pan G; Xie ZF; Zhang Y; Long SC; Xu XP; Zhang ZW
Genet Test Mol Biomarkers; 2014 Dec; 18(12):832-8. PubMed ID: 25330142
[TBL] [Abstract][Full Text] [Related]
3. [Effect of tongxinluo capsule on platelet aggregation in patients with cerebral infarction].
Liu F; Li J; Wang XD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Apr; 28(4):304-6. PubMed ID: 18543480
[TBL] [Abstract][Full Text] [Related]
4. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
[TBL] [Abstract][Full Text] [Related]
5. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
6. Platelet aggregation and P-selectin levels during exercise treadmill test in patients with ischaemic heart disease.
Kobusiak-Prokopowicz M; Kuliczkowski W; Karolko B; Prajs I; Mazurek W
Kardiol Pol; 2006 Oct; 64(10):1094-100; discussion 1101. PubMed ID: 17089241
[TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
[TBL] [Abstract][Full Text] [Related]
8. Effects of Quyu xiaoban capsules on clinical outcomes and platelet activation and aggregation in patients with unstable angina pectoris.
Liu YF; Yu HM; Zhang C; Yang RX; Yan FF; Liu Y; Zhang Y; Zhao YX
J Altern Complement Med; 2007 Apr; 13(3):369-74. PubMed ID: 17480139
[TBL] [Abstract][Full Text] [Related]
9. Effects of Quyu Xiaoban capsules on clinical outcomes and platelet activation and aggregation in patients with unstable angina pectoris.
Liu YF; Yu HM; Zhang C; Yang RX; Yan FF; Liu Y; Zhang Y; Zhao YX
J Altern Complement Med; 2007 Jun; 13(5):571-6. PubMed ID: 17604562
[TBL] [Abstract][Full Text] [Related]
10. [Effect of tongxinluo capsule on platelet aggregation function in patients with aspirin resistance].
Yin CH; Bi DP; Du M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Apr; 30(4):380-2. PubMed ID: 20669674
[TBL] [Abstract][Full Text] [Related]
11. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients.
Zisman E; Erport A; Kohanovsky E; Ballagulah M; Cassel A; Quitt M; Pizov R
Eur J Anaesthesiol; 2010 Jul; 27(7):617-23. PubMed ID: 20035230
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
13. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
14. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
[TBL] [Abstract][Full Text] [Related]
15. Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry.
Stellbaum C; Ayral Y; Morguet A; Schultheiss HP; Rauch U
Cardiovasc Revasc Med; 2012; 13(3):159-66. PubMed ID: 22503564
[TBL] [Abstract][Full Text] [Related]
16. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
18. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.
Xiao Z; Théroux P
J Am Coll Cardiol; 2004 Jun; 43(11):1982-8. PubMed ID: 15172401
[TBL] [Abstract][Full Text] [Related]
20. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
